Estrogen Dominance: What the Term Gets Right, and What It Sells
Body · The Reading Room · Evidence review · 8 min read · Which part of the idea has physiology behind it, which part is a sales category, and why the saliva test cannot settle it
Reviewed against the published work of JoAnn V. Pinkerton, MD, Professor of Obstetrics and Gynecology and Division Director of Midlife Health, University of Virginia, and co-author of the Endocrine Society’s scientific statement on compounded hormones. UVA Health profile · UVA Obstetrics and Gynecology · the statement on PubMed
The term describes something partly real. It is then used to sell a test that cannot measure it and a cream the evidence does not support.
The quiz takes four minutes. Breast tenderness, yes. Heavier periods, yes. Tired, irritable, a few pounds around the middle, a lower interest in sex than two years ago. Yes, yes, yes and, if pressed, yes.
The result page says estrogen dominance, with a link to a saliva kit and a jar of cream.
A reader who searches the term finds thousands of pages treating it as a settled diagnosis. This review asks a narrower question: what does the published evidence actually support? Informational, not medical advice. The findings belong to the researchers named below; the plain-English reading, and any error in it, belongs to Blue Leaf Journal.
The short answer: estrogen dominance is not a recognized medical diagnosis. Cleveland Clinic describes it as a label that “some healthcare providers” use for estrogen running high relative to progesterone.¹ Part of that picture is well documented: in perimenopause, estradiol can run higher and more erratically than before while progesterone falls,² and estrogen without enough progesterone can cause overgrowth of the uterine lining.¹ What is not supported is the popular version, a long list of everyday symptoms confirmed by a saliva or blood panel and treated with a custom cream. The Endocrine Society found no evidence that monitoring hormone therapy with serial salivary or blood testing is effective, and advises against custom-compounded hormones.³
The skim version
- Not a formal diagnosis. The term is used by some providers, not defined by diagnostic criteria.¹
- A real imbalance exists in perimenopause. In Jerilynn Prior’s data, follicular-phase estradiol averaged 225 pmol/L in perimenopausal women against 175 pmol/L in premenopausal women, while progesterone ran lower.²
- Unopposed estrogen matters for the uterus. Estrogen without enough progesterone can cause cell overgrowth, which is why abnormal bleeding needs a proper evaluation.¹
- The symptom lists are not specific. Breast tenderness, fatigue, mood swings, irregular periods, weight gain and low libido are also the common symptoms of the transition itself.¹
- The tests cannot settle it. Hormone levels swing through the cycle, so blood results in women who still menstruate may be inaccurate.¹ Serial salivary or blood monitoring of hormone therapy has no evidence of effectiveness.³
- Evidence grade: Contested. The physiology is partly real; the diagnosis and the products built on it are not established.
In this article: What the term means · The part that is real · Why the test cannot settle it · The evidence, claim by claim · How strong is this evidence? · The one move · FAQ
What is estrogen dominance?
In its popular form, estrogen dominance is the idea that estrogen is too high relative to progesterone, and that this imbalance explains a wide range of symptoms in women from their thirties onward. The phrase reached a mass readership through the books of John R. Lee, a physician who promoted natural progesterone cream, most widely through What Your Doctor May Not Tell You About Menopause.4
Cleveland Clinic’s patient information is careful with the wording. It describes high estrogen, notes that “some healthcare providers call this ‘estrogen dominance,’” and explains the underlying concern: when the body makes too much estrogen or not enough progesterone, the estrogen is unopposed, which can drive cell overgrowth.¹
That is the gap this review is about. There is a physiological concept, unopposed estrogen, that clinicians take seriously. And there is a consumer category, estrogen dominance, that borrows the concept and extends it much further than the evidence goes.
Is estrogen dominance real in perimenopause?
The honest answer is: partly, and in a specific way.
The most detailed case for a relative estrogen excess in perimenopause comes from Jerilynn Prior, an endocrinologist at the University of British Columbia. Her review reports follicular-phase estradiol averaging 175 pmol/L in premenopausal women and 225 pmol/L in perimenopausal women, roughly 30 percent higher, alongside lower progesterone, more cycles without ovulation and shorter luteal phases.² (The luteal phase is the second half of the cycle, when progesterone should be high.) Her list of early perimenopause signs includes new heavy or longer flow, sore or swollen breasts and increased cramps.²
So a woman in her mid-forties with heavier periods and tender breasts may well be experiencing an estrogen-progesterone imbalance. What the research describes, though, is largely a normal, temporary feature of the transition, and not something a single test confirms.
The clinically important consequence is the one Cleveland Clinic names: unopposed estrogen can cause overgrowth of cells.¹ In the uterus, that is why prolonged, heavy or irregular bleeding in perimenopause deserves an evaluation, and why women with a uterus who take estrogen as hormone therapy are prescribed a progestogen alongside it. That is standard medicine, and it does not need the label.
What the research found
The statement. Santoro, Braunstein, Butts, Martin, McDermott and Pinkerton, “Compounded Bioidentical Hormones in Endocrinology Practice: An Endocrine Society Scientific Statement”, Journal of Clinical Endocrinology and Metabolism, 2016.
The finding. “There is no evidence that monitoring compounded HT with serial salivary or blood testing is effective, except in the case of thyroid hormone.” For estrogen, progestin and DHEA, the practice of baseline hormone measurements to replace “abnormal” deficiencies “has no basis in medical practice.” The authors advise prescribing FDA-approved hormone products and avoiding custom-compounded hormones.³
The limitation: a scientific statement is an expert synthesis, not a new trial. It addresses testing and compounded products, and it does not use or evaluate the term estrogen dominance directly. Absence of evidence for a test is not proof that no imbalance exists; it means the test cannot be relied on to show one.
If the quiz result landed because it finally put a name to a pile of symptoms nobody else had connected, the pile is worth looking at properly, in one place, before buying anything. Start here.
The researcher behind this review
JoAnn V. Pinkerton, MD
Professor in the Department of Obstetrics and Gynecology at the University of Virginia and Division Director of Midlife Health. She founded UVA’s Midlife Health Center in 1993 to care for women over 40, covering perimenopause and menopause, heart and bone health, and cancer prevention. In 2025 UVA established the Women’s Midlife Health Endowed Professorship in her honor. She writes on menopause for clinicians through the MSD Manual Professional Edition and for the public through HealthyWomen.
What was read: Santoro, N., et al., with Pinkerton, J. V., Endocrine Society scientific statement, JCEM, 2016.³
Where to follow her work: UVA Health · UVA endowed professorship · MSD Manual author page · HealthyWomen articles · Society for Women’s Health Research · ResearchGate
Why can’t a saliva or blood test confirm estrogen dominance?
Because the thing being measured does not hold still long enough to be caught in one sample.
Estrogen and progesterone move substantially across a normal cycle. Cleveland Clinic notes that in people who still menstruate, blood tests for estrogen may be inaccurate for exactly that reason.¹ In perimenopause the swings widen: the late transition is characterized by cycles that are often anovulatory and hormone levels that are unpredictable from one month to the next.² A single result, or a ratio calculated from one result, describes a moment rather than a condition.
Salivary testing adds a further problem. The Endocrine Society’s statement found no evidence that serial salivary or blood monitoring of hormone therapy is effective, and described baseline measurements used to “replace abnormal deficiencies” as having no basis in medical practice.³ A kit that returns a precise-looking progesterone-to-estrogen ratio is offering a number without a validated meaning.
Estrogen dominance: the evidence, claim by claim
| Claim | What the evidence shows | Limitation |
|---|---|---|
| Estrogen can run high relative to progesterone in perimenopause | Supported. Higher average estradiol and lower progesterone in perimenopausal women² | Averages; individual women vary widely, and the pattern is temporary |
| Unopposed estrogen affects the uterine lining | Supported. It can cause cell overgrowth¹ | A reason to evaluate abnormal bleeding, not a diagnosis in itself |
| A symptom list can identify it | Not supported. The listed symptoms overlap heavily with the transition itself¹ | No validated criteria exist to separate the two |
| A saliva or blood panel can confirm it | Not supported. Levels fluctuate; serial monitoring lacks evidence¹³ | Statement addresses testing generally, not this label specifically |
| Custom-compounded creams correct it | Not supported. Endocrine Society advises FDA-approved products instead³ | Few trials of compounded products exist to judge either way |
How strong is this evidence?
Contested
The literature supports a relative estrogen excess in parts of perimenopause and takes unopposed estrogen seriously for the uterus.¹² It does not support estrogen dominance as a diagnosable condition with a defined symptom set, a reliable test or a proven compounded treatment.³ Pages that present it as settled are claiming more certainty than the evidence gives them.
Who else has measured this
Nanette F. Santoro, MD, E. Stewart Taylor Professor in the Department of Obstetrics and Gynecology at the University of Colorado Anschutz, was first author of the Endocrine Society statement. Her laboratory specializes in reproductive hormone measurement, which is part of why the statement’s verdict on testing carries weight.³
CU Anschutz faculty page · Endocrine Society profile · Aspen Ideas speaker page · ResearchGate
Jerilynn C. Prior, MD, FRCPC, Professor of Endocrinology and Metabolism at the University of British Columbia and founder of the Centre for Menstrual Cycle and Ovulation Research, published the data showing higher and more erratic estradiol with lower progesterone in perimenopause.²
CeMCOR biography · Wikipedia · her review in the BC Medical Journal
John R. Lee, MD, a physician and author, popularized the term estrogen dominance through his books on natural progesterone. He is cited here as the origin of the popular idea, not as a source of evidence for it.4
official website · What Your Doctor May Not Tell You About Menopause
A number without a validated meaning is still just a number.
When this belongs with a doctor
See a clinician for very heavy bleeding, bleeding lasting longer than usual, bleeding between periods or after sex, any bleeding after twelve months without a period, or a new breast lump. These deserve an examination, and sometimes an ultrasound or biopsy, whatever label a quiz has offered. Do not start a progesterone cream or other hormone product in place of that evaluation.
The sentence to take with you: “My periods have become heavier and my breasts are tender, and I have read about estrogen dominance. Can we check whether this is the transition, and whether my bleeding needs looking into?”
The one move: bring the pattern, not the kit
Before spending anything on a saliva test or a cream, write three lines.
First, the two or three symptoms that are actually costing you something, work, sleep or patience. Second, what your periods have done over the last six months: heavier, longer, closer together, further apart. Third, any bleeding that has worried you.
That short record is more useful to a clinician than a salivary ratio, because it describes the pattern the evidence says matters.²³ It also keeps the conversation on the part of estrogen dominance that is real, the bleeding and the transition, and away from the part that is for sale.
Common questions
Is estrogen dominance a real diagnosis?
No. It is a term some healthcare providers use for estrogen running high relative to progesterone, but it is not defined by recognized diagnostic criteria.¹ The underlying physiology, unopposed estrogen, is real and clinically relevant.
What are the symptoms of estrogen dominance?
Lists usually include breast tenderness, fatigue, mood swings, irregular periods, weight gain and low libido.¹ These are also common symptoms of perimenopause, so the list cannot tell the two apart.
Can a saliva test diagnose estrogen dominance?
No reliable evidence supports it. The Endocrine Society found no evidence that serial salivary or blood hormone monitoring is effective for guiding hormone therapy, and hormone levels in menstruating women fluctuate too much for one test to be definitive.¹³
Is estrogen dominance the same as perimenopause?
They overlap. In perimenopause, estradiol can run higher and more erratically while progesterone falls, which is the imbalance the term describes.² The difference is that perimenopause is a normal, temporary transition rather than a disorder.
Does progesterone cream fix estrogen dominance?
That has not been established. The Endocrine Society advises using FDA-approved hormone products rather than custom-compounded ones.³ Any hormone treatment is a decision to make with a clinician.
The one move
Skip the kit. Write three lines: the symptoms that cost you most, what your periods have done in six months, and any bleeding that worried you. Take them to a clinician.
If the quiz was the first thing that seemed to connect everything, it may help to see the whole picture laid out without a product at the end of it. Start here.
Part of the idea is physiology. The rest is a shopping cart.
Related reading: why the cycle loses its timing in perimenopause, what regulated hormone therapy is and is not, and why the week before your period got harder.
On the researchers. JoAnn Pinkerton and Nanette Santoro are cited for a scientific statement on compounded hormones and testing; neither addresses the term estrogen dominance in it, and neither is your clinician. Jerilynn Prior is cited for her data on perimenopausal hormone levels. John Lee is cited as the popularizer of the term, not as an evidence source.
Sourcing, disclosure and disclaimers
This is not medical advice. Blue Leaf Journal publishes general information for a general readership. Nothing here is a diagnosis, a treatment recommendation, or a substitute for care from a clinician who knows your history. Informational, not medical advice: see your clinician.
We are not clinicians. Blue Leaf Journal is an independent publication and its bylines carry no medical or academic credential. We read published research and translate it. The findings belong to the researchers and institutions named and linked above; the plain-English rendering is ours, and so is any error in it.
No affiliation and no endorsement. Blue Leaf Journal is not affiliated with JoAnn V. Pinkerton, Nanette F. Santoro, Jerilynn C. Prior, John R. Lee, the University of Virginia, the University of Colorado, the University of British Columbia, the Centre for Menstrual Cycle and Ovulation Research, the Endocrine Society or Cleveland Clinic. None of them has reviewed, approved or endorsed this article, and none of them is responsible for it.
No commercial relationship. Nobody named above paid for or was paid for this coverage. There are no affiliate links, no sponsored placements and no product recommendations in this article.
How this was checked. Every figure above was checked against the cited source on 16 September 2026, and each source is linked below. If you find something we have got wrong, write to norawhitfield@blueleafjournal.com and we will correct it and say that we did.
References
1. Cleveland Clinic, “High Estrogen: Causes, Symptoms, Dominance and Treatment”.
2. Prior, J. C. “Clearing confusion about perimenopause.” British Columbia Medical Journal, 2005, 47(10). bcmj.org
3. Santoro, N., Braunstein, G. D., Butts, C. L., Martin, K. A., McDermott, M., Pinkerton, J. V. “Compounded Bioidentical Hormones in Endocrinology Practice: An Endocrine Society Scientific Statement.” Journal of Clinical Endocrinology and Metabolism, 2016, 101(4):1318. Endocrine Society · JCEM · PubMed
4. Lee, J. R., and Hopkins, V. What Your Doctor May Not Tell You About Menopause. Cited for the origin of the popular term.
Keep reading
Miriam Alderton is Research Editor at Blue Leaf Journal. She reads the methods section first and the abstract last, and every figure in this piece is linked to its source below.
Written by Miriam Alderton for Blue Leaf Journal. Updated: 16 September 2026.
